Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Stock Short Interest Climbs 108.7%

Columbia Research Enhanced Value ETF (NYSEARCA:REVS) was the target of a large growth in short interest in September. As of September 30th, there was short interest totaling 50,920 shares, a growth of 108.7% from the September 15th total of 24,397 shares. Based on an average daily trading volume, of 60,698 shares, the days-to-cover ratio is presently 0.8 days. Approximately 0.5% of the shares of the company are short sold.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of REVS. Envestnet Asset Management Inc. raised its stake in shares of Columbia Research Enhanced Value ETF by 13.9% during the second quarter. Envestnet Asset Management Inc. now owns 361,667 shares of the company’s stock valued at $11,371,000 after purchasing an additional 44,147 shares in the last quarter. Ruggaard & Associates LLC grew its position in Columbia Research Enhanced Value ETF by 0.6% in the 1st quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock valued at $1,500,000 after buying an additional 322 shares in the last quarter. World Investment Advisors grew its position in Columbia Research Enhanced Value ETF by 12.8% in the 1st quarter. World Investment Advisors now owns 46,609 shares of the company’s stock valued at $1,334,000 after buying an additional 5,283 shares in the last quarter. First Interstate Bank bought a new position in Columbia Research Enhanced Value ETF in the 1st quarter valued at about $1,321,000. Finally, Private Advisor Group LLC increased its stake in Columbia Research Enhanced Value ETF by 2.2% during the 1st quarter. Private Advisor Group LLC now owns 42,408 shares of the company’s stock valued at $1,214,000 after buying an additional 922 shares during the period.

Columbia Research Enhanced Value ETF Price Performance

REVS opened at $33.76 on Wednesday. The stock’s 50 day moving average price is $33.67 and its 200 day moving average price is $32.08. The stock has a market cap of $371.36 million, a P/E ratio of 16.41 and a beta of 0.79. Columbia Research Enhanced Value ETF has a 12 month low of $27.24 and a 12 month high of $34.55.

About Columbia Research Enhanced Value ETF

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.